Do analysts rate ADVB or BNAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Brand Engagement Network 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate ADVB or NTWK?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 NetSol Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate IDN or ADVB?

Intellicheck presently has a consensus target price of $6.50, indicating a potential upside of 168.04%. Given Intellicheck's stronger consensus rating and higher probable upside, analysts clearly believe Intellicheck is more favorable than Advanced Biomed. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intellicheck 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate ADVB or YHNA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 YHN Acquisition I 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, ADVB or YHNA?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Advanced Biomed N/A N/A -$3.26M $4.82 1.34 YHN Acquisition I N/A N/A N/A N/A N/A

Is ADVB or YHNA more profitable?

Advanced Biomed's return on equity of 87.74% beat YHN Acquisition I's return on equity. Company Net Margins Return on Equity Return on Assets Advanced Biomed N/A 87.74% 64.49% YHN Acquisition I N/A N/A N/A

Do analysts recommend ADVB or VHC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Virnetx 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ADVB or VHC more profitable?

Advanced Biomed's return on equity of 87.74% beat Virnetx's return on equity. Company Net Margins Return on Equity Return on Assets Advanced Biomed N/A 87.74% 64.49% Virnetx N/A -92.46% -66.74%

Advanced Biomed (ADVB) Competitors

$6.47 +0.16 (+2.54%)

As of 01:43 PM Eastern

Compare

ADVB vs. BNAI, NTWK, IDN, YHNA, and VHC

Should you buy Advanced Biomed stock or one of its competitors? Advanced Biomed's main competitors and comparable companies include Brand Engagement Network (BNAI), NetSol Technologies (NTWK), Intellicheck (IDN), YHN Acquisition I (YHNA), and Virnetx (VHC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Advanced Biomed compare to Brand Engagement Network?

Advanced Biomed (NASDAQ:ADVB) and Brand Engagement Network (NASDAQ:BNAI) are both small-cap technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Brand Engagement Network	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Advanced Biomed has a beta of -0.29, meaning that its share price is 129% less volatile than the broader market. Comparatively, Brand Engagement Network has a beta of 0.44, meaning that its share price is 56% less volatile than the broader market.

In the previous week, Brand Engagement Network had 3 more articles in the media than Advanced Biomed. MarketBeat recorded 5 mentions for Brand Engagement Network and 2 mentions for Advanced Biomed. Advanced Biomed's average media sentiment score of 1.43 beat Brand Engagement Network's score of 0.76 indicating that Advanced Biomed is being referred to more favorably in the media.

Company	Overall Sentiment
Advanced Biomed	Positive
Brand Engagement Network	Positive

Advanced Biomed has a net margin of 0.00% compared to Brand Engagement Network's net margin of -2,356.26%. Advanced Biomed's return on equity of 87.74% beat Brand Engagement Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
Brand Engagement Network	-2,356.26%	-145.56%	-62.22%

15.8% of Brand Engagement Network shares are owned by institutional investors. 27.0% of Advanced Biomed shares are owned by company insiders. Comparatively, 25.6% of Brand Engagement Network shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Advanced Biomed has higher earnings, but lower revenue than Brand Engagement Network. Brand Engagement Network is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.34
Brand Engagement Network	$280K	167.05	-$8.62M	-$1.60	N/A

Summary

Advanced Biomed beats Brand Engagement Network on 8 of the 12 factors compared between the two stocks.

How does Advanced Biomed compare to NetSol Technologies?

Advanced Biomed (NASDAQ:ADVB) and NetSol Technologies (NASDAQ:NTWK) are both small-cap technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

In the previous week, Advanced Biomed and Advanced Biomed both had 2 articles in the media. Advanced Biomed's average media sentiment score of 1.43 beat NetSol Technologies' score of 0.84 indicating that Advanced Biomed is being referred to more favorably in the media.

Company	Overall Sentiment
Advanced Biomed	Positive
NetSol Technologies	Positive

NetSol Technologies has a net margin of 2.49% compared to Advanced Biomed's net margin of 0.00%. Advanced Biomed's return on equity of 87.74% beat NetSol Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
NetSol Technologies	2.49%	4.24%	2.76%

NetSol Technologies has higher revenue and earnings than Advanced Biomed. Advanced Biomed is trading at a lower price-to-earnings ratio than NetSol Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.34
NetSol Technologies	$66.09M	0.88	$2.92M	$0.15	32.70

Advanced Biomed has a beta of -0.29, indicating that its share price is 129% less volatile than the broader market. Comparatively, NetSol Technologies has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NetSol Technologies	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

16.0% of NetSol Technologies shares are held by institutional investors. 27.0% of Advanced Biomed shares are held by insiders. Comparatively, 13.5% of NetSol Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

NetSol Technologies beats Advanced Biomed on 7 of the 12 factors compared between the two stocks.

How does Advanced Biomed compare to Intellicheck?

Intellicheck (NASDAQ:IDN) and Advanced Biomed (NASDAQ:ADVB) are both small-cap technology companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

Intellicheck has higher revenue and earnings than Advanced Biomed. Advanced Biomed is trading at a lower price-to-earnings ratio than Intellicheck, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intellicheck	$22.67M	2.17	$1.27M	$0.15	16.17
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.34

Intellicheck presently has a consensus target price of $6.50, indicating a potential upside of 168.04%. Given Intellicheck's stronger consensus rating and higher probable upside, analysts clearly believe Intellicheck is more favorable than Advanced Biomed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intellicheck	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Intellicheck has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market. Comparatively, Advanced Biomed has a beta of -0.29, indicating that its stock price is 129% less volatile than the broader market.

42.8% of Intellicheck shares are owned by institutional investors. 7.8% of Intellicheck shares are owned by insiders. Comparatively, 27.0% of Advanced Biomed shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Advanced Biomed had 1 more articles in the media than Intellicheck. MarketBeat recorded 2 mentions for Advanced Biomed and 1 mentions for Intellicheck. Advanced Biomed's average media sentiment score of 1.43 beat Intellicheck's score of 1.00 indicating that Advanced Biomed is being referred to more favorably in the news media.

Company	Overall Sentiment
Intellicheck	Positive
Advanced Biomed	Positive

Intellicheck has a net margin of 13.03% compared to Advanced Biomed's net margin of 0.00%. Advanced Biomed's return on equity of 87.74% beat Intellicheck's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intellicheck	13.03%	15.02%	12.27%
Advanced Biomed	N/A	87.74%	64.49%

Summary

Intellicheck beats Advanced Biomed on 9 of the 15 factors compared between the two stocks.

How does Advanced Biomed compare to YHN Acquisition I?

Advanced Biomed (NASDAQ:ADVB) and YHN Acquisition I (NASDAQ:YHNA) are both small-cap technology companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, dividends, earnings and risk.

Advanced Biomed has a beta of -0.29, meaning that its share price is 129% less volatile than the broader market. Comparatively, YHN Acquisition I has a beta of 0.01, meaning that its share price is 99% less volatile than the broader market.

In the previous week, Advanced Biomed and Advanced Biomed both had 2 articles in the media. Advanced Biomed's average media sentiment score of 1.43 beat YHN Acquisition I's score of 1.41 indicating that Advanced Biomed is being referred to more favorably in the media.

Company	Overall Sentiment
Advanced Biomed	Positive
YHN Acquisition I	Positive

Advanced Biomed's return on equity of 87.74% beat YHN Acquisition I's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
YHN Acquisition I	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
YHN Acquisition I	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.34
YHN Acquisition I	N/A	N/A	N/A	N/A	N/A

Summary

Advanced Biomed beats YHN Acquisition I on 3 of the 4 factors compared between the two stocks.

How does Advanced Biomed compare to Virnetx?

Advanced Biomed (NASDAQ:ADVB) and Virnetx (NASDAQ:VHC) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations.

Advanced Biomed has a beta of -0.29, suggesting that its share price is 129% less volatile than the broader market. Comparatively, Virnetx has a beta of 2.28, suggesting that its share price is 128% more volatile than the broader market.

Advanced Biomed has higher earnings, but lower revenue than Virnetx. Virnetx is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.34
Virnetx	$160K	286.23	-$18.23M	-$5.37	N/A

Advanced Biomed's return on equity of 87.74% beat Virnetx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
Virnetx	N/A	-92.46%	-66.74%

10.4% of Virnetx shares are owned by institutional investors. 27.0% of Advanced Biomed shares are owned by company insiders. Comparatively, 15.7% of Virnetx shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Virnetx	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Advanced Biomed had 1 more articles in the media than Virnetx. MarketBeat recorded 2 mentions for Advanced Biomed and 1 mentions for Virnetx. Virnetx's average media sentiment score of 1.82 beat Advanced Biomed's score of 1.43 indicating that Virnetx is being referred to more favorably in the news media.

Company	Overall Sentiment
Advanced Biomed	Positive
Virnetx	Very Positive

Summary

Advanced Biomed beats Virnetx on 7 of the 11 factors compared between the two stocks.

Get Advanced Biomed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADVB vs. The Competition

Export

Metric	Advanced Biomed	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$10.67M	$16.09B	$31.16B	$13.16B
Dividend Yield	N/A	3.42%	2.74%	12.57%
P/E Ratio	1.34	142.15	79.44	25.84
Price / Sales	N/A	1,283.57	589.80	110.94
Price / Cash	N/A	47.54	49.70	52.76
Price / Book	2.02	8.77	7.97	6.33
Net Income	-$3.26M	$432.51M	$702.31M	$359.77M
7 Day Performance	-1.07%	0.76%	1.36%	-0.03%
1 Month Performance	-29.52%	-2.72%	-1.61%	-3.96%
1 Year Performance	N/A	-0.15%	179.18%	6.32%

Advanced Biomed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADVB Advanced Biomed	1.3714 of 5 stars	$6.47 +2.5%	N/A	N/A	$10.67M	N/A	1.34	31	Positive News Short Interest Decrease
BNAI Brand Engagement Network	0.1738 of 5 stars	$6.84 -2.1%	N/A	+122.9%	$52.38M	$280K	N/A	29
NTWK NetSol Technologies	1.183 of 5 stars	$4.26 +0.9%	N/A	+1.5%	$50.12M	$66.09M	28.40	1,460	News Coverage Gap Up High Trading Volume
IDN Intellicheck	3.3245 of 5 stars	$2.38 -2.1%	$6.50 +173.1%	-56.7%	$49.25M	$22.67M	15.87	38	Positive News
YHNA YHN Acquisition I	1.4083 of 5 stars	$11.09 -0.5%	N/A	N/A	$47.79M	N/A	N/A	N/A	Positive News Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADVB) was last updated on 9/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Advanced Biomed (ADVB) Competitors

ADVB vs. BNAI, NTWK, IDN, YHNA, and VHC

How does Advanced Biomed compare to Brand Engagement Network?

Summary

How does Advanced Biomed compare to NetSol Technologies?

Summary

How does Advanced Biomed compare to Intellicheck?

Summary

How does Advanced Biomed compare to YHN Acquisition I?

Summary

How does Advanced Biomed compare to Virnetx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADVB vs. The Competition

Advanced Biomed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Advanced Biomed (ADVB) Competitors

ADVB vs. BNAI, NTWK, IDN, YHNA, and VHC

How does Advanced Biomed compare to Brand Engagement Network?

Do analysts rate ADVB or BNAI?

Which has more risk & volatility, ADVB or BNAI?

Does the media favor ADVB or BNAI?

Is ADVB or BNAI more profitable?

Do insiders and institutionals have more ownership in ADVB or BNAI?

Which has higher earnings and valuation, ADVB or BNAI?

Summary

How does Advanced Biomed compare to NetSol Technologies?

Does the media refer more to ADVB or NTWK?

Is ADVB or NTWK more profitable?

Which has preferable valuation and earnings, ADVB or NTWK?

Which has more volatility & risk, ADVB or NTWK?

Do analysts rate ADVB or NTWK?

Do insiders & institutionals have more ownership in ADVB or NTWK?

Summary

How does Advanced Biomed compare to Intellicheck?

Which has stronger valuation and earnings, IDN or ADVB?

Do analysts rate IDN or ADVB?

Which has more risk & volatility, IDN or ADVB?

Do institutionals & insiders believe in IDN or ADVB?

Does the media refer more to IDN or ADVB?

Is IDN or ADVB more profitable?

Summary

How does Advanced Biomed compare to YHN Acquisition I?

Which has more volatility and risk, ADVB or YHNA?

Does the media favor ADVB or YHNA?

Is ADVB or YHNA more profitable?

Do analysts rate ADVB or YHNA?

Which has stronger earnings and valuation, ADVB or YHNA?

Summary

How does Advanced Biomed compare to Virnetx?

Which has more volatility & risk, ADVB or VHC?

Which has better valuation & earnings, ADVB or VHC?

Is ADVB or VHC more profitable?

Do insiders & institutionals have more ownership in ADVB or VHC?

Do analysts recommend ADVB or VHC?

Does the media prefer ADVB or VHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADVB vs. The Competition

Advanced Biomed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools